ArticleOdontology2026
Dysregulation of miR-140-3p is involved in the pathogenesis of pulpitis via the regulation of ACSL1.
Article in Odontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Pulpitis is an inflammatory disease affecting the dental pulp tissue, impacting patients' oral health and daily life. MicroRNAs (miRNAs) are involved in the progression of pulpitis. This study aims to elucidate the regulatory role of the miR-140-3p/ACSL1 axis in pulpitis, particularly its molecular mechanisms within dental pulp cells. The levels of miR-140-3p and long-chain acyl CoA synthetase 1 (ACSL1) was measured by RT-qPCR. The receiver operating characteristic (ROC) curve represented the diagnostic capability of miR-140-3p. Lipopolysaccharide (LPS) derived from Escherichia coli was applied to mimic pulp tissue inflammation in vitro. Inflammatory markers were tested via ELISA. Bioinformatics tools predicted miR-140-3p target sites. Target relationships were validated by dual-luciferase reporter assay. The expression of miR-140-3p was downregulated in inflamed pulp tissue, and it could distinguish between healthy individuals and pulpitis patients. In vitro, the miR-140-3p mimic enhanced proliferation and superoxide dismutase (SOD) activity while reducing apoptosis and the levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), and malondialdehyde (MDA) in LPS-treated hDPCs. These situations were abolished by ACSL1. In conclusion, low levels of miR-140-3p were involved in the progression of pulpitis. By negatively regulating ACSL1, miR-140-3p promotes proliferation while suppressing apoptosis, inflammation, and oxidative stress, thereby alleviating pulpitis.
Indexed as
Identifiers
41518489What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.